Itau Unibanco Holding S.A. Revance Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$11.66 - $20.15 $18,224 - $31,494	-1,563 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.67 - $15.49 $2,923 - $4,244	-274 Reduced 14.92%	1,563 $20,000
Q4 2018 Feb 13, 2019	BUY	$18.06 - $24.96 $1,246 - $1,722	69 Added 3.9%	1,837 $36,000
Q3 2018 Nov 13, 2018	SELL	$23.55 - $30.1 $3,461 - $4,424	-147 Reduced 7.68%	1,768 $44,000
Q2 2018 Aug 13, 2018	SELL	$27.45 - $33.35 $7,493 - $9,104	-273 Reduced 12.48%	1,915 $52,000
Q1 2018 May 14, 2018	BUY	$29.15 - $37.4 $38,186 - $48,994	1,310 Added 149.2%	2,188 $67,000
Q4 2017 Feb 09, 2018	BUY	$24.55 - $36.3 $8,175 - $12,087	333 Added 61.1%	878 $31,000
Q3 2017 Nov 14, 2017	BUY	$22.55 - $28.1 $12,289 - $15,314	545	545 $48,000

223

81M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.